SCHEMBL11026450

SCHEMBL11026450

COC(=O)c1cc(C)c2c(c1)C(C)(C)CC(c1cccc(Br)c1)N2

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ POLB P06746 2/20 0.40
▸ LMNA P02545 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ F10 P00742 1/20 0.37
▸ F11 P03951 1/20 0.37
▸ F7 P08709 1/20 0.37
▸ KMT2A Q03164 3/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ MAPT P10636 4/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ GUSB P08236 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ NOTCH1 P46531 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45455 0.83 F11 (0.49) TSHRNPSR1POLBLMNARECQL
SCHEMBL2140705 0.82 TSHR (0.41) TSHRNPSR1POLBLMNARECQL
SCHEMBL11029270 0.81 MRGPRX4 (0.40) POLBKMT2AMAPTALDH1A1MEN1
SCHEMBL11028491 0.81 F10 (0.44) TSHRNPSR1POLBLMNARECQL
SCHEMBL11025003 0.81 TSHR (0.39) TSHRNPSR1POLBLMNARECQL
SCHEMBL2138997 0.81 TSHR (0.39) TSHRNPSR1POLBLMNARECQL
SCHEMBL2136714 0.79 KMT2A (0.36) NPSR1POLBLMNAKMT2AALDH1A1
SCHEMBL2135138 0.77 L3MBTL1 (0.38) NPSR1POLBLMNAF10F11
SCHEMBL11024121 0.75 TP53 (0.44) POLBF10F11F7KMT2A
SCHEMBL11024272 0.73 F11 (0.47) TSHRNPSR1POLBLMNARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809369-B2 Tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2014-08-19 — — US disclosed
EP-2668165-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2013-12-04 — — EP disclosed
WO-2012101068-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2012-08-02 — — WO disclosed
US-20120190677-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190677-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES RAB1A, RABL3, RAB7A TSHR 779/4885NPSR1 766/4885POLB 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback